Waltz Health and Noom have joined forces to enhance GLP-1 management by launching a comprehensive and cost-effective weight loss program.
This program focuses on managing GLP-1 prescriptions, which are effective in treating obesity and related cardiovascular issues. The collaboration aims to streamline access to specialty medications and enhance patient engagement through Waltz Connect, an end-to-end solution.
Waltz Connect manages specialty medication coverage, facilitates patient access to prescribed medications, and ensures the application of available discounts. The partnership also aims to enhance price transparency by allowing employees to view their medication costs in advance through the Noom app.
This collaboration addresses the financial burden of obesity, which costs U.S. businesses approximately $425.5 billion annually. By integrating evidence-based obesity care with behavioral change programs, the joint offering aims to facilitate sustained weight loss and reduce employer healthcare costs.
Waltz Connect is a flexible platform that can be tailored to specific drug classes, such as GLP-1s, and is built on Waltz Health's Intelligent Specialty Engine, an AI-driven prescription routing software. This software identifies the most suitable specialty pharmacy options based on criteria set by each payer, enhancing medication access efficiency and fostering competition among specialty pharmacies.
Waltz Health's commitment to improving healthcare affordability and accessibility is further demonstrated by its foray into the Medicare Advantage sector. The company offers health plans that support customizable configurations of its proprietary Marketplace Search technology, which lowers prescription drug prices for Medicare beneficiaries. The Marketplace Search tool can also assist health plan members in navigating coverage gaps, identifying lower-cost cash-pay solutions for non-covered medications, and accessing patient-assistance programs. This approach aligns with broader healthcare goals of reducing costs and improving outcomes.
The collaboration between Waltz Health and Noom represents a significant step towards addressing the challenges posed by obesity and the associated financial burdens. By combining innovative technology with evidence-based care, this partnership is poised to make a meaningful impact on the lives of employees and the organizations that support them.